Robin Deterding
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 36 | 2025 | 592 | 7.800 |
Why?
| Pulmonary Surfactant-Associated Protein C | 9 | 2023 | 43 | 2.320 |
Why?
| Neuroendocrine Cells | 9 | 2020 | 32 | 2.180 |
Why?
| Respiration Disorders | 5 | 2019 | 72 | 1.690 |
Why?
| Bronchoalveolar Lavage Fluid | 7 | 2019 | 624 | 1.600 |
Why?
| Hyperplasia | 12 | 2022 | 170 | 1.580 |
Why?
| Glycogen Storage Disease | 3 | 2021 | 19 | 1.470 |
Why?
| Lung | 30 | 2024 | 3748 | 1.270 |
Why?
| Idiopathic Pulmonary Fibrosis | 6 | 2024 | 623 | 1.230 |
Why?
| Infant | 44 | 2025 | 9001 | 1.100 |
Why?
| Child | 73 | 2025 | 20805 | 1.100 |
Why?
| Cystic Fibrosis | 7 | 2019 | 1049 | 0.980 |
Why?
| Child, Preschool | 40 | 2025 | 10487 | 0.950 |
Why?
| Proteomics | 6 | 2023 | 1018 | 0.920 |
Why?
| Machine Learning | 2 | 2019 | 444 | 0.910 |
Why?
| Pediatrics | 8 | 2015 | 1050 | 0.900 |
Why?
| Tomography, X-Ray Computed | 17 | 2024 | 2517 | 0.830 |
Why?
| Oxygen Inhalation Therapy | 5 | 2019 | 141 | 0.810 |
Why?
| Mutation | 14 | 2024 | 3696 | 0.730 |
Why?
| Bronchiectasis | 3 | 2024 | 108 | 0.730 |
Why?
| Humans | 109 | 2025 | 128499 | 0.700 |
Why?
| Immunologic Techniques | 1 | 2019 | 38 | 0.670 |
Why?
| Allergy and Immunology | 1 | 2019 | 43 | 0.630 |
Why?
| Biopsy | 15 | 2019 | 1079 | 0.630 |
Why?
| Home Care Services | 2 | 2019 | 244 | 0.620 |
Why?
| Sleep Wake Disorders | 2 | 2020 | 250 | 0.610 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 6 | 0.600 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 101 | 0.590 |
Why?
| Aptamers, Nucleotide | 1 | 2019 | 77 | 0.580 |
Why?
| Asthma | 3 | 2019 | 2213 | 0.570 |
Why?
| Lung Diseases | 8 | 2020 | 715 | 0.560 |
Why?
| Hypoxia | 4 | 2018 | 1035 | 0.560 |
Why?
| Respiratory Function Tests | 12 | 2024 | 580 | 0.560 |
Why?
| Deoxycytosine Nucleotides | 2 | 2007 | 11 | 0.520 |
Why?
| Uridine | 2 | 2007 | 29 | 0.520 |
Why?
| Male | 53 | 2025 | 63045 | 0.500 |
Why?
| Pulmonary Alveoli | 7 | 2021 | 365 | 0.490 |
Why?
| Female | 52 | 2025 | 68268 | 0.480 |
Why?
| Hypertension, Pulmonary | 7 | 2024 | 1749 | 0.470 |
Why?
| Pulmonary Surfactants | 8 | 2013 | 105 | 0.470 |
Why?
| Bronchiolitis Obliterans | 4 | 2024 | 64 | 0.460 |
Why?
| Adolescent | 34 | 2025 | 20304 | 0.440 |
Why?
| Clinical Clerkship | 6 | 2007 | 95 | 0.440 |
Why?
| Household Articles | 1 | 2014 | 24 | 0.440 |
Why?
| Research | 2 | 2020 | 409 | 0.430 |
Why?
| Respiration, Artificial | 4 | 2021 | 604 | 0.430 |
Why?
| Disinfectants | 1 | 2014 | 35 | 0.430 |
Why?
| Pulmonary Surfactant-Associated Protein B | 3 | 2010 | 5 | 0.420 |
Why?
| Retrospective Studies | 25 | 2024 | 14472 | 0.410 |
Why?
| Growth Substances | 6 | 2000 | 150 | 0.410 |
Why?
| Bronchiolitis | 1 | 2013 | 87 | 0.400 |
Why?
| Esophagoscopy | 3 | 2019 | 195 | 0.380 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2011 | 18 | 0.370 |
Why?
| International Classification of Diseases | 1 | 2012 | 122 | 0.370 |
Why?
| Neurosecretory Systems | 3 | 2010 | 31 | 0.370 |
Why?
| ATP-Binding Cassette Transporters | 5 | 2014 | 130 | 0.370 |
Why?
| Program Development | 2 | 2018 | 357 | 0.360 |
Why?
| Infant, Newborn | 17 | 2019 | 5740 | 0.350 |
Why?
| Humidity | 1 | 2011 | 49 | 0.350 |
Why?
| Potassium Channels | 1 | 2011 | 144 | 0.350 |
Why?
| Fibroblast Growth Factors | 5 | 2000 | 170 | 0.350 |
Why?
| Dust | 1 | 2011 | 94 | 0.340 |
Why?
| Computer Simulation | 4 | 2018 | 939 | 0.340 |
Why?
| Inhalation Exposure | 1 | 2011 | 89 | 0.340 |
Why?
| Education, Medical, Undergraduate | 3 | 2007 | 176 | 0.330 |
Why?
| Rare Diseases | 3 | 2020 | 100 | 0.330 |
Why?
| Pulmonary Alveolar Proteinosis | 2 | 2023 | 17 | 0.330 |
Why?
| Diagnosis, Differential | 6 | 2019 | 1412 | 0.330 |
Why?
| Problem-Based Learning | 4 | 2006 | 77 | 0.330 |
Why?
| Purinergic P2 Receptor Agonists | 2 | 2007 | 4 | 0.310 |
Why?
| Hematopoietic Stem Cell Transplantation | 2 | 2024 | 575 | 0.310 |
Why?
| Eosinophilic Esophagitis | 3 | 2019 | 318 | 0.310 |
Why?
| Immunologic Factors | 2 | 2011 | 231 | 0.300 |
Why?
| Pulmonary Fibrosis | 2 | 2024 | 377 | 0.300 |
Why?
| Autoimmune Diseases | 3 | 2024 | 424 | 0.300 |
Why?
| Tomography | 2 | 2018 | 24 | 0.300 |
Why?
| Lung Injury | 1 | 2011 | 199 | 0.290 |
Why?
| Curriculum | 2 | 2007 | 910 | 0.280 |
Why?
| Case-Control Studies | 6 | 2019 | 3339 | 0.280 |
Why?
| Respiratory Tract Diseases | 2 | 2019 | 148 | 0.270 |
Why?
| Cytokines | 2 | 2019 | 1994 | 0.270 |
Why?
| Practice Guidelines as Topic | 4 | 2024 | 1490 | 0.270 |
Why?
| Gastrointestinal Diseases | 2 | 2018 | 196 | 0.260 |
Why?
| Pneumonia | 2 | 2019 | 601 | 0.250 |
Why?
| United States | 12 | 2025 | 13840 | 0.250 |
Why?
| Genetic Testing | 2 | 2025 | 428 | 0.240 |
Why?
| Vital Capacity | 2 | 2024 | 291 | 0.240 |
Why?
| Double-Blind Method | 3 | 2023 | 1856 | 0.240 |
Why?
| Disease Progression | 3 | 2024 | 2604 | 0.230 |
Why?
| Bronchodilator Agents | 1 | 2006 | 243 | 0.230 |
Why?
| Receptors, CCR2 | 1 | 2023 | 37 | 0.220 |
Why?
| Fibrosis | 2 | 2024 | 513 | 0.210 |
Why?
| Hernia, Diaphragmatic | 1 | 2003 | 69 | 0.210 |
Why?
| Deglutition | 1 | 2024 | 67 | 0.210 |
Why?
| Pleural Effusion | 1 | 2003 | 50 | 0.210 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 335 | 0.210 |
Why?
| Biomarkers | 5 | 2019 | 3893 | 0.200 |
Why?
| Severity of Illness Index | 4 | 2020 | 2719 | 0.200 |
Why?
| Thyroid Nuclear Factor 1 | 3 | 2019 | 15 | 0.200 |
Why?
| Bronchoscopy | 3 | 2018 | 208 | 0.190 |
Why?
| Self-Evaluation Programs | 2 | 1999 | 6 | 0.190 |
Why?
| Arthritis, Juvenile | 2 | 2019 | 53 | 0.190 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2024 | 217 | 0.190 |
Why?
| Education, Medical | 1 | 2005 | 244 | 0.190 |
Why?
| Heart Defects, Congenital | 3 | 2018 | 750 | 0.190 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 93 | 0.180 |
Why?
| Immunocompromised Host | 2 | 2015 | 196 | 0.180 |
Why?
| Protein C | 1 | 2021 | 47 | 0.180 |
Why?
| Stevens-Johnson Syndrome | 1 | 2021 | 38 | 0.180 |
Why?
| Indoles | 1 | 2024 | 372 | 0.180 |
Why?
| Pulmonary Medicine | 2 | 2019 | 78 | 0.170 |
Why?
| Thinking | 1 | 2001 | 56 | 0.170 |
Why?
| Immunologic Deficiency Syndromes | 1 | 2000 | 62 | 0.170 |
Why?
| Foundations | 2 | 2020 | 24 | 0.170 |
Why?
| Proteolipids | 2 | 2000 | 30 | 0.170 |
Why?
| Heart Diseases | 1 | 2023 | 347 | 0.160 |
Why?
| Respiratory Rate | 1 | 2019 | 20 | 0.160 |
Why?
| Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 2269 | 0.160 |
Why?
| Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| Infant, Newborn, Diseases | 1 | 2001 | 109 | 0.160 |
Why?
| Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| Otorhinolaryngologic Diseases | 1 | 2019 | 14 | 0.160 |
Why?
| Digestive System Diseases | 1 | 2019 | 25 | 0.160 |
Why?
| User-Computer Interface | 3 | 2006 | 148 | 0.160 |
Why?
| Registries | 2 | 2025 | 1883 | 0.160 |
Why?
| Societies | 1 | 2019 | 36 | 0.160 |
Why?
| Preceptorship | 1 | 1999 | 65 | 0.150 |
Why?
| Oximetry | 1 | 2019 | 87 | 0.150 |
Why?
| Educational Measurement | 1 | 2001 | 257 | 0.150 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2019 | 101 | 0.150 |
Why?
| Air | 1 | 2018 | 36 | 0.150 |
Why?
| Colorado | 6 | 2019 | 4399 | 0.150 |
Why?
| Bronchi | 2 | 2015 | 241 | 0.150 |
Why?
| Esophageal Mucosa | 1 | 2018 | 19 | 0.150 |
Why?
| Virtual Reality | 1 | 2019 | 51 | 0.150 |
Why?
| Adult | 14 | 2024 | 35302 | 0.140 |
Why?
| Models, Anatomic | 1 | 2018 | 89 | 0.140 |
Why?
| Radiography | 3 | 2013 | 795 | 0.140 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 99 | 0.140 |
Why?
| Fibroblast Growth Factor 1 | 2 | 1996 | 12 | 0.140 |
Why?
| Pneumonia, Lipid | 1 | 2017 | 3 | 0.140 |
Why?
| Research Design | 2 | 2023 | 1036 | 0.140 |
Why?
| Respiration | 1 | 2018 | 190 | 0.140 |
Why?
| Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| Bronchial Arteries | 1 | 2017 | 12 | 0.140 |
Why?
| Respiratory Sounds | 2 | 2010 | 120 | 0.140 |
Why?
| Autophagy | 2 | 2022 | 265 | 0.140 |
Why?
| Polysomnography | 1 | 2018 | 161 | 0.140 |
Why?
| Lymphocytes | 1 | 2019 | 368 | 0.140 |
Why?
| Prognosis | 6 | 2024 | 3780 | 0.140 |
Why?
| Internal Medicine | 1 | 1999 | 246 | 0.130 |
Why?
| Down Syndrome | 1 | 2023 | 471 | 0.130 |
Why?
| Gastroesophageal Reflux | 2 | 2015 | 230 | 0.130 |
Why?
| Gastrostomy | 1 | 2018 | 110 | 0.130 |
Why?
| Disease Management | 3 | 2019 | 584 | 0.130 |
Why?
| Membrane Proteins | 2 | 2022 | 1109 | 0.130 |
Why?
| Delivery of Health Care, Integrated | 1 | 2019 | 240 | 0.130 |
Why?
| Pulmonary Artery | 2 | 2024 | 1031 | 0.130 |
Why?
| Clinical Competence | 3 | 2018 | 1009 | 0.130 |
Why?
| Lung Transplantation | 2 | 2015 | 278 | 0.120 |
Why?
| Mutation, Missense | 2 | 2014 | 315 | 0.120 |
Why?
| Young Adult | 8 | 2019 | 12349 | 0.120 |
Why?
| Bleomycin | 1 | 1997 | 241 | 0.120 |
Why?
| Esophageal Atresia | 1 | 2015 | 24 | 0.120 |
Why?
| Pulmonary Surgical Procedures | 1 | 2015 | 8 | 0.120 |
Why?
| Imaging, Three-Dimensional | 2 | 2017 | 529 | 0.120 |
Why?
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 29 | 0.120 |
Why?
| Comorbidity | 1 | 2020 | 1541 | 0.120 |
Why?
| Tracheoesophageal Fistula | 1 | 2015 | 33 | 0.120 |
Why?
| Thyroid Gland | 1 | 2015 | 94 | 0.120 |
Why?
| Family Practice | 1 | 1999 | 434 | 0.120 |
Why?
| Patient Satisfaction | 2 | 2019 | 626 | 0.120 |
Why?
| Gestational Age | 1 | 2018 | 871 | 0.120 |
Why?
| Pregnancy Trimester, First | 1 | 2015 | 138 | 0.120 |
Why?
| Heart Rate | 1 | 2019 | 798 | 0.120 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 1003 | 0.120 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 518 | 0.120 |
Why?
| Patient Care Team | 2 | 2018 | 598 | 0.120 |
Why?
| Delayed Diagnosis | 1 | 2015 | 79 | 0.120 |
Why?
| Angiography | 1 | 2015 | 192 | 0.120 |
Why?
| Pluripotent Stem Cells | 1 | 2015 | 78 | 0.120 |
Why?
| Genetic Diseases, Inborn | 1 | 2014 | 38 | 0.110 |
Why?
| Phenotype | 3 | 2018 | 3051 | 0.110 |
Why?
| Chest Tubes | 1 | 2014 | 29 | 0.110 |
Why?
| Forced Expiratory Volume | 3 | 2024 | 511 | 0.110 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 43 | 0.110 |
Why?
| Societies, Medical | 2 | 2019 | 744 | 0.110 |
Why?
| Regeneration | 1 | 2015 | 176 | 0.110 |
Why?
| Cell Differentiation | 3 | 2015 | 1900 | 0.110 |
Why?
| Deglutition Disorders | 1 | 2015 | 132 | 0.110 |
Why?
| Electric Impedance | 3 | 2018 | 101 | 0.110 |
Why?
| Ambulatory Care | 1 | 2018 | 504 | 0.110 |
Why?
| Abnormalities, Multiple | 1 | 2015 | 178 | 0.110 |
Why?
| Airway Obstruction | 1 | 2015 | 149 | 0.110 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 737 | 0.110 |
Why?
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 5 | 0.110 |
Why?
| Blood Proteins | 1 | 2015 | 240 | 0.110 |
Why?
| Treatment Outcome | 6 | 2015 | 10162 | 0.110 |
Why?
| DNA Mutational Analysis | 2 | 2013 | 385 | 0.110 |
Why?
| Autoimmunity | 1 | 2019 | 860 | 0.110 |
Why?
| Homozygote | 1 | 2013 | 193 | 0.110 |
Why?
| Follow-Up Studies | 4 | 2019 | 4874 | 0.100 |
Why?
| Evidence-Based Medicine | 1 | 2017 | 712 | 0.100 |
Why?
| Software | 1 | 1998 | 608 | 0.100 |
Why?
| Pedigree | 2 | 2013 | 485 | 0.100 |
Why?
| Glycoproteins | 2 | 2000 | 337 | 0.100 |
Why?
| Device Removal | 1 | 2014 | 134 | 0.100 |
Why?
| Schools, Medical | 2 | 2007 | 130 | 0.100 |
Why?
| Mucin-5B | 1 | 2015 | 217 | 0.100 |
Why?
| Plethysmography | 1 | 2012 | 107 | 0.100 |
Why?
| Critical Care | 1 | 2017 | 551 | 0.100 |
Why?
| Autoantibodies | 3 | 2019 | 1464 | 0.100 |
Why?
| Familial Primary Pulmonary Hypertension | 2 | 2024 | 183 | 0.100 |
Why?
| Fibroblast Growth Factor 7 | 5 | 2000 | 16 | 0.100 |
Why?
| Fibroblast Growth Factor 10 | 5 | 2000 | 24 | 0.100 |
Why?
| Leukocytes | 1 | 2013 | 303 | 0.100 |
Why?
| World Health Organization | 1 | 2012 | 110 | 0.100 |
Why?
| Spirometry | 1 | 2012 | 254 | 0.100 |
Why?
| Premature Birth | 1 | 2015 | 310 | 0.100 |
Why?
| Cardiac Catheterization | 1 | 2015 | 517 | 0.100 |
Why?
| Models, Statistical | 1 | 2015 | 622 | 0.090 |
Why?
| Internship and Residency | 2 | 2018 | 1045 | 0.090 |
Why?
| Hydrocortisone | 1 | 1994 | 304 | 0.090 |
Why?
| Genetic Counseling | 2 | 2015 | 72 | 0.090 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 87 | 0.090 |
Why?
| Rats, Sprague-Dawley | 5 | 1997 | 2272 | 0.090 |
Why?
| Bronchoalveolar Lavage | 3 | 2007 | 89 | 0.090 |
Why?
| Bromhexine | 1 | 2010 | 1 | 0.090 |
Why?
| Laryngeal Diseases | 1 | 2011 | 27 | 0.090 |
Why?
| Physicians | 1 | 2019 | 863 | 0.090 |
Why?
| Granulomatosis with Polyangiitis | 1 | 2011 | 42 | 0.090 |
Why?
| Rats | 8 | 2000 | 5246 | 0.090 |
Why?
| Epithelial Cells | 4 | 2015 | 1043 | 0.090 |
Why?
| Syndrome | 1 | 2011 | 336 | 0.090 |
Why?
| Rituximab | 1 | 2011 | 162 | 0.090 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2011 | 92 | 0.090 |
Why?
| Endoscopy, Digestive System | 2 | 2024 | 122 | 0.090 |
Why?
| Intestinal Mucosa | 1 | 2015 | 581 | 0.080 |
Why?
| Nuclear Proteins | 2 | 2013 | 658 | 0.080 |
Why?
| Referral and Consultation | 1 | 2015 | 728 | 0.080 |
Why?
| Diagnostic Imaging | 2 | 2015 | 332 | 0.080 |
Why?
| Uniparental Disomy | 1 | 2009 | 7 | 0.080 |
Why?
| Microscopy, Electron | 3 | 2013 | 419 | 0.080 |
Why?
| Anti-Bacterial Agents | 2 | 2013 | 1705 | 0.080 |
Why?
| Esophagus | 2 | 2024 | 248 | 0.080 |
Why?
| Uteroglobin | 2 | 2000 | 21 | 0.080 |
Why?
| Mucin-1 | 1 | 2009 | 20 | 0.080 |
Why?
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 19 | 0.080 |
Why?
| Body Mass Index | 1 | 2017 | 2263 | 0.080 |
Why?
| Neutrophils | 1 | 2013 | 1192 | 0.070 |
Why?
| Cell Division | 4 | 2000 | 777 | 0.070 |
Why?
| DNA | 2 | 2013 | 1394 | 0.070 |
Why?
| Cytogenetic Analysis | 1 | 2007 | 33 | 0.070 |
Why?
| Lung Volume Measurements | 1 | 2007 | 43 | 0.070 |
Why?
| Medical History Taking | 2 | 2005 | 116 | 0.070 |
Why?
| Nebulizers and Vaporizers | 1 | 2007 | 81 | 0.070 |
Why?
| Transcription Factors | 2 | 2013 | 1635 | 0.070 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 372 | 0.070 |
Why?
| Delphi Technique | 2 | 2018 | 222 | 0.060 |
Why?
| Logistic Models | 3 | 2015 | 1980 | 0.060 |
Why?
| DNA, Bacterial | 1 | 2007 | 324 | 0.060 |
Why?
| Consensus | 2 | 2020 | 610 | 0.060 |
Why?
| Cough | 1 | 2007 | 115 | 0.060 |
Why?
| Computer-Assisted Instruction | 1 | 2006 | 59 | 0.060 |
Why?
| Animals | 12 | 2019 | 34647 | 0.060 |
Why?
| Cross-Sectional Studies | 2 | 2015 | 5045 | 0.060 |
Why?
| Receptors, Purinergic P2Y2 | 1 | 2005 | 6 | 0.060 |
Why?
| Prospective Studies | 4 | 2023 | 7069 | 0.060 |
Why?
| Administration, Inhalation | 2 | 2005 | 661 | 0.060 |
Why?
| Respiratory Mucosa | 2 | 2014 | 304 | 0.060 |
Why?
| Intraoperative Period | 2 | 2015 | 53 | 0.060 |
Why?
| Age Distribution | 1 | 2005 | 373 | 0.060 |
Why?
| Faculty, Medical | 1 | 2007 | 263 | 0.060 |
Why?
| Program Evaluation | 2 | 2019 | 872 | 0.060 |
Why?
| Teaching | 1 | 2006 | 210 | 0.060 |
Why?
| Age of Onset | 1 | 2005 | 495 | 0.050 |
Why?
| Pulmonary Veno-Occlusive Disease | 1 | 2003 | 10 | 0.050 |
Why?
| T-Box Domain Proteins | 1 | 2024 | 96 | 0.050 |
Why?
| Patient Simulation | 1 | 2003 | 31 | 0.050 |
Why?
| Cohort Studies | 3 | 2023 | 5402 | 0.050 |
Why?
| Macrophages, Alveolar | 2 | 2023 | 375 | 0.050 |
Why?
| Autophagy-Related Proteins | 1 | 2022 | 41 | 0.050 |
Why?
| Methylprednisolone | 2 | 2013 | 82 | 0.050 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 40 | 0.050 |
Why?
| Terminology as Topic | 2 | 2018 | 199 | 0.050 |
Why?
| Neuroblastoma | 1 | 2003 | 153 | 0.050 |
Why?
| Bayes Theorem | 1 | 2024 | 373 | 0.050 |
Why?
| Bone Marrow Transplantation | 1 | 2003 | 269 | 0.050 |
Why?
| Data Collection | 1 | 2005 | 649 | 0.050 |
Why?
| Vesicular Transport Proteins | 1 | 2022 | 84 | 0.050 |
Why?
| Genotype | 2 | 2018 | 1830 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 152 | 0.050 |
Why?
| Disease Models, Animal | 3 | 2019 | 3947 | 0.050 |
Why?
| Cross-Cultural Comparison | 1 | 2001 | 82 | 0.050 |
Why?
| Bacteria | 1 | 2007 | 817 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 229 | 0.050 |
Why?
| RNA, Messenger | 4 | 2000 | 2679 | 0.040 |
Why?
| Surface-Active Agents | 1 | 2021 | 84 | 0.040 |
Why?
| Group Processes | 1 | 2001 | 57 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1201 | 0.040 |
Why?
| Neoplasms | 1 | 2015 | 2463 | 0.040 |
Why?
| Models, Educational | 1 | 2001 | 86 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 9 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2015 | 1668 | 0.040 |
Why?
| Pemphigus | 1 | 1999 | 8 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 539 | 0.040 |
Why?
| Developing Countries | 1 | 2001 | 286 | 0.040 |
Why?
| Paraneoplastic Syndromes | 1 | 1999 | 11 | 0.040 |
Why?
| Heart | 1 | 2023 | 637 | 0.040 |
Why?
| Incidence | 2 | 2019 | 2638 | 0.040 |
Why?
| Speech-Language Pathology | 1 | 2019 | 19 | 0.040 |
Why?
| Anti-Inflammatory Agents | 2 | 2013 | 470 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Protein D | 2 | 2000 | 35 | 0.040 |
Why?
| Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| Survival Rate | 2 | 2019 | 1871 | 0.040 |
Why?
| Hospital Information Systems | 1 | 1998 | 14 | 0.040 |
Why?
| NF-kappa B | 1 | 2022 | 650 | 0.040 |
Why?
| Formative Feedback | 1 | 2018 | 26 | 0.040 |
Why?
| Computer Communication Networks | 1 | 1998 | 32 | 0.040 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 97 | 0.040 |
Why?
| Students, Medical | 1 | 2002 | 315 | 0.040 |
Why?
| Efficiency, Organizational | 1 | 2019 | 133 | 0.040 |
Why?
| Interdisciplinary Research | 1 | 2018 | 26 | 0.040 |
Why?
| Otolaryngology | 1 | 2019 | 84 | 0.040 |
Why?
| Drug Antagonism | 1 | 1997 | 10 | 0.040 |
Why?
| Fundoplication | 1 | 1997 | 54 | 0.030 |
Why?
| Hydroxyproline | 1 | 1997 | 22 | 0.030 |
Why?
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 222 | 0.030 |
Why?
| Macrophage Activation Syndrome | 1 | 2017 | 21 | 0.030 |
Why?
| Information Storage and Retrieval | 1 | 1998 | 108 | 0.030 |
Why?
| Gene Expression | 3 | 2000 | 1455 | 0.030 |
Why?
| Early Diagnosis | 1 | 2018 | 234 | 0.030 |
Why?
| Review Literature as Topic | 1 | 2017 | 66 | 0.030 |
Why?
| Hydrochloric Acid | 1 | 1996 | 8 | 0.030 |
Why?
| Trachea | 1 | 2018 | 221 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1996 | 24 | 0.030 |
Why?
| Cholera Toxin | 1 | 1996 | 31 | 0.030 |
Why?
| Gastroenterology | 1 | 2019 | 174 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2019 | 260 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 228 | 0.030 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 65 | 0.030 |
Why?
| Analysis of Variance | 1 | 1999 | 1273 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2018 | 264 | 0.030 |
Why?
| Organ Size | 1 | 1997 | 441 | 0.030 |
Why?
| Culture Media | 1 | 1996 | 164 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2023 | 2710 | 0.030 |
Why?
| Cyclic AMP | 1 | 1996 | 231 | 0.030 |
Why?
| Xenopus | 1 | 2015 | 85 | 0.030 |
Why?
| Respiratory Insufficiency | 1 | 1999 | 311 | 0.030 |
Why?
| Sampling Studies | 1 | 2015 | 96 | 0.030 |
Why?
| Embryonic Induction | 1 | 1995 | 31 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2019 | 509 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2015 | 182 | 0.030 |
Why?
| Laminin | 1 | 1995 | 68 | 0.030 |
Why?
| Mice | 3 | 2019 | 16620 | 0.030 |
Why?
| Mouth | 1 | 2015 | 80 | 0.030 |
Why?
| Health Services Research | 1 | 2018 | 389 | 0.030 |
Why?
| Autophagy-Related Protein 8 Family | 1 | 2014 | 2 | 0.030 |
Why?
| Vimentin | 1 | 1995 | 50 | 0.030 |
Why?
| Demography | 1 | 2015 | 278 | 0.030 |
Why?
| Long-Term Care | 1 | 2015 | 91 | 0.030 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2015 | 56 | 0.030 |
Why?
| Proteostasis Deficiencies | 1 | 2014 | 5 | 0.030 |
Why?
| Sequestosome-1 Protein | 1 | 2014 | 13 | 0.030 |
Why?
| Vacuoles | 1 | 2014 | 36 | 0.030 |
Why?
| Hepatocyte Growth Factor | 1 | 1994 | 33 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2014 | 2516 | 0.030 |
Why?
| Proteoglycans | 1 | 1995 | 109 | 0.030 |
Why?
| North America | 1 | 2015 | 290 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2014 | 68 | 0.030 |
Why?
| Prevalence | 2 | 2011 | 2553 | 0.030 |
Why?
| Fatal Outcome | 2 | 2009 | 301 | 0.030 |
Why?
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 185 | 0.030 |
Why?
| Mesoderm | 1 | 1995 | 136 | 0.030 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 136 | 0.030 |
Why?
| Quality of Health Care | 1 | 2019 | 606 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 502 | 0.030 |
Why?
| Drug Combinations | 1 | 1995 | 324 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 80 | 0.030 |
Why?
| Lysosomes | 1 | 2014 | 135 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2015 | 152 | 0.030 |
Why?
| rab GTP-Binding Proteins | 1 | 2014 | 72 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1994 | 92 | 0.030 |
Why?
| Microfilament Proteins | 1 | 2014 | 125 | 0.030 |
Why?
| Consanguinity | 1 | 2013 | 47 | 0.030 |
Why?
| B-Lymphocytes | 1 | 2019 | 814 | 0.030 |
Why?
| Rats, Inbred F344 | 3 | 2000 | 255 | 0.030 |
Why?
| Genes, Recessive | 1 | 2013 | 76 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2014 | 281 | 0.030 |
Why?
| Hydroxychloroquine | 1 | 2013 | 55 | 0.030 |
Why?
| Drainage | 1 | 2014 | 165 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1047 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2014 | 153 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2014 | 189 | 0.030 |
Why?
| Radiography, Thoracic | 1 | 2014 | 164 | 0.030 |
Why?
| Laparoscopy | 1 | 1997 | 450 | 0.030 |
Why?
| Azithromycin | 1 | 2013 | 92 | 0.030 |
Why?
| Siblings | 1 | 2013 | 215 | 0.030 |
Why?
| Collagen | 1 | 1995 | 430 | 0.030 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 203 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 883 | 0.030 |
Why?
| Maternal-Fetal Exchange | 1 | 1994 | 161 | 0.030 |
Why?
| Middle Aged | 2 | 2019 | 30923 | 0.020 |
Why?
| Pandemics | 1 | 2020 | 1477 | 0.020 |
Why?
| Mice, Knockout | 1 | 2019 | 2765 | 0.020 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 281 | 0.020 |
Why?
| Pregnancy | 2 | 2015 | 6373 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 2013 | 165 | 0.020 |
Why?
| Pain, Postoperative | 1 | 2014 | 222 | 0.020 |
Why?
| HEK293 Cells | 1 | 2014 | 683 | 0.020 |
Why?
| Algorithms | 2 | 2015 | 1614 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 392 | 0.020 |
Why?
| Congresses as Topic | 1 | 2013 | 211 | 0.020 |
Why?
| Dexamethasone | 1 | 1994 | 345 | 0.020 |
Why?
| Denmark | 1 | 2011 | 44 | 0.020 |
Why?
| Risk Factors | 2 | 2015 | 9737 | 0.020 |
Why?
| Laryngostenosis | 1 | 2011 | 28 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2019 | 1923 | 0.020 |
Why?
| Granuloma | 1 | 2011 | 83 | 0.020 |
Why?
| Cells, Cultured | 2 | 1995 | 4017 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 1199 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2015 | 2069 | 0.020 |
Why?
| Nitric Oxide | 1 | 2015 | 881 | 0.020 |
Why?
| Cell Line | 1 | 2015 | 2741 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1568 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2014 | 499 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.020 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 30 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 5281 | 0.020 |
Why?
| Mitochondria | 1 | 2014 | 855 | 0.020 |
Why?
| Time Factors | 1 | 2019 | 6506 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 2 | 2000 | 60 | 0.020 |
Why?
| DNA Methylation | 1 | 2013 | 607 | 0.020 |
Why?
| Genes, rRNA | 1 | 2007 | 41 | 0.020 |
Why?
| Biomedical Research | 1 | 2014 | 633 | 0.020 |
Why?
| Endocrine System Diseases | 1 | 2007 | 33 | 0.020 |
Why?
| Genes, Bacterial | 1 | 2007 | 158 | 0.020 |
Why?
| Growth Disorders | 1 | 2007 | 80 | 0.020 |
Why?
| Risk Assessment | 1 | 2015 | 3232 | 0.020 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 953 | 0.020 |
Why?
| Chronic Disease | 1 | 2011 | 1692 | 0.010 |
Why?
| Nervous System Diseases | 1 | 2007 | 252 | 0.010 |
Why?
| Postoperative Complications | 1 | 2015 | 2462 | 0.010 |
Why?
| CD-ROM | 1 | 2003 | 6 | 0.010 |
Why?
| Signal Transduction | 1 | 1996 | 4825 | 0.010 |
Why?
| Proteins | 2 | 2000 | 936 | 0.010 |
Why?
| Teaching Materials | 1 | 2003 | 22 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2822 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2666 | 0.010 |
Why?
| Transplantation, Autologous | 1 | 2003 | 211 | 0.010 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 419 | 0.010 |
Why?
| Korea | 1 | 2001 | 9 | 0.010 |
Why?
| Adenovirus Infections, Human | 1 | 2001 | 14 | 0.010 |
Why?
| Pneumonia, Mycoplasma | 1 | 2001 | 57 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 2000 | 77 | 0.010 |
Why?
| Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 35 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 291 | 0.010 |
Why?
| Acantholysis | 1 | 1999 | 2 | 0.010 |
Why?
| Castleman Disease | 1 | 1999 | 13 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2003 | 1292 | 0.010 |
Why?
| Internet | 1 | 2003 | 613 | 0.010 |
Why?
| Epithelium | 1 | 1999 | 306 | 0.010 |
Why?
| Lymphoma, B-Cell | 1 | 1999 | 105 | 0.010 |
Why?
| Adolescent Behavior | 1 | 2003 | 505 | 0.010 |
Why?
| Phospholipases A | 1 | 1997 | 99 | 0.010 |
Why?
| Clinical Protocols | 1 | 1998 | 254 | 0.010 |
Why?
| Physical Examination | 1 | 1998 | 233 | 0.010 |
Why?
| Cell Count | 1 | 1996 | 310 | 0.010 |
Why?
| Influenza, Human | 1 | 2001 | 600 | 0.010 |
Why?
| Attitude of Health Personnel | 1 | 2002 | 1090 | 0.010 |
Why?
| Immunoglobulin G | 1 | 1999 | 844 | 0.010 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 1994 | 74 | 0.010 |
Why?
| Age Factors | 1 | 2000 | 3122 | 0.010 |
Why?
|
|
Deterding's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|